MARKET

TNDM

TNDM

Tandem Diabetes
NASDAQ
35.12
+0.15
+0.43%
After Hours: 34.46 -0.66 -1.88% 16:17 04/24 EDT
OPEN
34.95
PREV CLOSE
34.97
HIGH
35.56
LOW
34.36
VOLUME
997.28K
TURNOVER
0
52 WEEK HIGH
40.74
52 WEEK LOW
13.82
MARKET CAP
2.27B
P/E (TTM)
-10.2498
1D
5D
1M
3M
1Y
5Y
Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care
Tandem Diabetes Care (NASDAQ:TNDM) has an average price target of $34.0. The company's 12-month price targets have increased by 26.87% from the previous average of $26.80. 5 analysts have provided ratings for Tandem diabetes care in the past three months. The firm designs, manufactures, and markets durable insulin pumps for diabetes patients.
Benzinga · 1d ago
Tandem Diabetes Care Is Maintained at Buy by Stifel
Dow Jones · 1d ago
Tandem Diabetes Care Price Target Raised to $40.00/Share From $37.00 by Stifel
Dow Jones · 1d ago
Stifel Maintains Buy on Tandem Diabetes Care, Raises Price Target to $40
Benzinga · 1d ago
TANDEM DIABETES CARE INC <TNDM.O>: STIFEL RAISES TARGET PRICE TO $40 FROM $37
Reuters · 1d ago
Weekly Report: what happened at TNDM last week (0415-0419)?
Weekly Report · 2d ago
TNDM Crosses Above Average Analyst Target
NASDAQ · 04/17 13:55
Weekly Report: what happened at TNDM last week (0408-0412)?
Weekly Report · 04/15 11:18
More
About TNDM
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Webull offers Tandem Diabetes Care Inc stock information, including NASDAQ: TNDM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNDM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNDM stock methods without spending real money on the virtual paper trading platform.